Certain antibody therapies have demonstrated the potential for directing a patient’s own immune system against tumors. Further advances in this area will depend upon a detailed understanding of the tumor microenvironment and characterization of the location and status of immune cells and their interaction with tumor cells. This will require methods that provide phenotyping of immune and cancer cells combined with information about their spatial relationship in tumor regions. Additionally, a deeper understanding of the signaling cascades active in immune recognition of cancers is crucial. During this webinar, we will discuss the bringing together of multiplexed fluorescent immunohistochemistry, advanced microscopy techniques, and bioinformatics, and how these are now enabling new insights into cancer biology and immunology.
During this webinar viewers will be able to ask questions of the panelists and will learn about:
- Cutting-edge research targeting the B-cell receptor signaling pathway that has recently demonstrated therapeutic promise
- Methods that can provide in depth information on cancer phenotypes, including simultaneous immunohistochemistry of multiple biomarkers, multiplexed imaging, single cell quantitative analysis, and automated phenotyping
- How host-tumor interaction analysis in breast cancers could form the basis for assays to guide therapy and monitor response.
To learn more about products or technologies related to this webinar, go to: www.perkinelmer.com/cancer-immunology